Format
Items per page
Sort by

Send to:

Choose Destination

Results: 9

Cited In for PubMed (Select 17436092)

1.

Management of depression induced by interferon hepatitis therapies.

Shah H, Kadia S, Bawa R, Lippmann S.

Prim Care Companion CNS Disord. 2013;15(5). pii: PCC.12r01487. doi: 10.4088/PCC.12r01487. Epub 2013 Sep 5.

2.

Does prophylactic antidepressant treatment boost interferon-alpha treatment completion in HCV?

Rowan PJ.

World J Virol. 2013 Nov 12;2(4):139-45. doi: 10.5501/wjv.v2.i4.139. Review.

3.
4.

Psychiatric treatment considerations with direct acting antivirals in hepatitis C.

Sockalingam S, Tseng A, Giguere P, Wong D.

BMC Gastroenterol. 2013 May 14;13:86. doi: 10.1186/1471-230X-13-86. Review.

5.

Risk factors for the development of depression in patients with hepatitis C taking interferon-α.

Smith KJ, Norris S, O'Farrelly C, O'Mara SM.

Neuropsychiatr Dis Treat. 2011;7:275-92. doi: 10.2147/NDT.S13917. Epub 2011 May 15.

6.

Psychiatric care of the patient with hepatitis C: a review of the literature.

Rifai MA, Gleason OC, Sabouni D.

Prim Care Companion J Clin Psychiatry. 2010;12(6). pii: PCC.09r00877. doi: 10.4088/PCC.09r00877whi.

7.

Inflammation in depression: is adiposity a cause?

Shelton RC, Miller AH.

Dialogues Clin Neurosci. 2011;13(1):41-53.

8.

Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression.

Shelton RC, Miller AH.

Prog Neurobiol. 2010 Aug;91(4):275-99. doi: 10.1016/j.pneurobio.2010.04.004. Epub 2010 Apr 22. Review.

9.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk